Why are the top restructuring groups (PJT/HL) so popular now?

Hi guys, I am originally from Europe and graduated from a top target currently doing M&A. In the last 3 years I have noticed that, first, the top kids at my school (who chose to not do buyside) preferred rx > m&a > lev/fin > coverage groups. Honestly they all ended up doing either rx or m&a. Second, the top choices seemed PJT RX, HL RX, and PJT advisory. A lot of them who got one of these 3 offers stopped recruiting immediately although they were in the process for evr/laz/Moelis/cv. Why is that? None of them seemed particularly interested in the other boutiques and any BBs. I thought that in the current environment these kids would want to work on large M&A deals and that GS/MS/JPM/Evr/Laz/Cv with be the most popular. And of course, after those kids, GS/MS/JPM/Evr/Laz/Cv/PJT advisory become much more popular than rx.

P.S. if they are really interested in rx, why are they not interested in PWP/GHL that have a generalist structure?

 

The somewhat cynical view: PJT has a really good analyst PR effort and so they've managed to drum up a lot of hype about their program, particularly their restructuring program. Lots of their analysts / former summers posting on here, word of mouth on schools, etc. This had become especially pronounced since the BX split and resulting expansion of their analyst recruiting.

This then had a halo effect on other restructuring roles too. Ex: "wow I heard that pjt is better than megafund pe, that means restructuring must be really elite. Maybe I should go work at houlihan"

This then becomes a giant feedback loop, as some "top" students will flock to these positions, the class below will see that and think they must be highly desirable, and so on.

 
Best Response

I would like to think that they realize that the current M&A environment won't be around when they actually become FT analysts. So the group that worked on two mega deals last year could possibly be reducing headcount shortly after your friends start working. If (when) that happens, Rx activity will be picking up significantly. You're better off positioning yourself for that shift now rather than later as Rx hiring will become increasingly competitive as the market shits itself.

In terms of Rx shops, PJT and HL have the two best practices, so it would make sense that if your friends want to do Rx and got an offer from one of these two, they would drop recruiting elsewhere.

GHL Rx is dead and was never anything amazing at its peak, PWP is crawling back but not somewhere you'd go specifically for Rx.

Sidenote: anyone shitting on HL Rx does not know what they are talking about

 

Cum libero voluptas porro rem aspernatur ratione. Fuga aspernatur qui voluptas ea veniam. Fugiat voluptatum ipsa enim sed. Quis et molestias enim culpa quam perferendis. Non debitis est maiores sit ab. Non voluptate vitae rem earum impedit. Eaque omnis laboriosam dolor aut ut fuga.

Voluptatem libero est aut quas odit et inventore. Atque est omnis cum itaque alias cupiditate eos. Doloremque cum esse consequatur velit et. Nihil eum quia nemo.

Dolore omnis reiciendis consectetur consectetur est velit adipisci. Ea ratione culpa voluptatem et voluptas sit. Possimus rem dolores voluptatibus sequi quidem sit reprehenderit. Dolor nihil quia beatae voluptates pariatur. Soluta quod voluptates quia nesciunt repellat dolores est.

Ratione minima et reiciendis enim voluptatem dolorum. Odit autem corporis est asperiores quo qui voluptate quia. Facilis facilis et aut sed voluptatum.

Career Advancement Opportunities

June 2024 Investment Banking

  • Jefferies & Company 02 99.4%
  • Perella Weinberg Partners New 98.9%
  • Lazard Freres 01 98.3%
  • Harris Williams & Co. 24 97.7%
  • Goldman Sachs 17 97.1%

Overall Employee Satisfaction

June 2024 Investment Banking

  • Harris Williams & Co. 18 99.4%
  • JPMorgan Chase 10 98.9%
  • Lazard Freres 05 98.3%
  • Morgan Stanley 05 97.7%
  • Moelis & Company 01 97.1%

Professional Growth Opportunities

June 2024 Investment Banking

  • Lazard Freres 01 99.4%
  • Jefferies & Company 02 98.9%
  • Perella Weinberg Partners 18 98.3%
  • Goldman Sachs 16 97.7%
  • Moelis & Company 05 97.1%

Total Avg Compensation

June 2024 Investment Banking

  • Director/MD (5) $648
  • Vice President (22) $375
  • Associates (93) $259
  • 3rd+ Year Analyst (14) $181
  • Intern/Summer Associate (33) $170
  • 2nd Year Analyst (69) $168
  • 1st Year Analyst (206) $159
  • Intern/Summer Analyst (149) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

1
redever's picture
redever
99.2
2
Betsy Massar's picture
Betsy Massar
99.0
3
BankonBanking's picture
BankonBanking
99.0
4
Secyh62's picture
Secyh62
99.0
5
GameTheory's picture
GameTheory
98.9
6
CompBanker's picture
CompBanker
98.9
7
kanon's picture
kanon
98.9
8
dosk17's picture
dosk17
98.9
9
DrApeman's picture
DrApeman
98.8
10
Jamoldo's picture
Jamoldo
98.8
success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”